Generic Pharmaceuticals Businesses for Sale and Investment Opportunities in India

1. The business operates in the generic pharmaceuticals industry, offering a wide range of tablets except narcotics-related products. 2. Located in Baddi, the company adheres to Good Manufacturing Practice (GMP) and World Health Organization (WHO) Drugs and Cosmetics guidelines for its machinery and facilities. 3. The business boasts Microbiological and Chemical laboratories compliant with the latest guidelines, ensuring quality control and regulatory compliance. 5. The owner, who has prior experience in manufacturing and runs a successful marketing company, possesses valuable connections within the pharmaceutical industry. 6. With plans to operate at 50% capacity in the next 6 months, the business projects sales of over INR 50 crores, with an expected net profit of INR 8 crores, reflecting a strong revenue and profitability outlook. 7. The business benefits from the owner's industry expertise and established relationships with pharmaceutical clients, which may contribute to its growth and success. 8. The focus on generic pharmaceuticals and compliance with industry standards positions the business to capitalize on the growing demand for affordable and accessible medication. 9. The company was incorporated in 2019 but was not able to start operations due to the covid crisis, the promoters are looking to start the business now and are also work on the lab to ensure that the required licenses are in place.

- Drug manufacturing business based in Hyderabad. - Company has around 60% spare capacity that can be immediately utilised for interested investors. - The average order value is INR 15L and we are supplying to 30 pharmaceutical companies. - We have all the licenses like factory license, pollution control board and drug license. - Having in-house solvent recovery facilities enables optimum solvent recoveries and minimizes handling losses. - Licensed Capacity: Large capacity of 930 MT p. a. can cater to future expansions without going for any fresh statutory approvals. - GMP Local GMP from DCA, Telangana. Facility can be easily scaled to WHO GMP & other regulatory approvals. - Private limited company is not part of the sale.

- Business manufacturing soft gel capsules which are distributed and sold through distribution partners. - 100+ distributing partners with PAN India supply. - Having a top-notch factory following the European Union guidelines. - We are GMP certified. The average order value is INR 5L. - Have a production capacity value of INR 50cr per month. - Our business is registered in Pune and we are operating from Roorkee, Uttarakhand. - There has been a drop in sales as the owners are not able to focus and give time to the business and hence want to sell it.

- We have been manufacturing cum sales suppliers to 165+ hospitals cum dialysis centers. - We have 18 hemodialysis products and also sell to 2 outsourced dialyzer cleaning solutions. - Manufacturing capacity is over 5 crore litres annually. - We comply with all the regulatory requirements applicable to the products. - The company is registered in Mumbai but the operations are based out of Bhiwandi.

• Established pharmaceutical manufacturing & distribution business with a presence in India for a decade. • Extensive product portfolio of 200 own-branded products including tablets, capsules, injectables, creams & ointments, and protein powders. • Robust network of new and old distributors across India. • Manufacturing partnerships with reputable pharmaceutical companies and an experienced team of shareholders and directors. • Lucrative opportunity for entrepreneurs and investors to enter or expand their presence in the pharmaceutical market. • Ready-made business infrastructure, strong distributor network, a wide range of trademarked products, and solid brand reputation. • The location of the premises is ideally situated for efficient distribution and accessibility to major transportation routes. • Due to the pandemic effect last year, our sales figures were high, and for this year we have been projected to make close to INR 50 lakh.

Developed highly niche products with almost no worldwide competition. All products have 50-60% profit margins going up to 200% profit margin. Fits in low volume - High margin product category. We cannot expand due to financial restrictions only & lack of 4-5 months working capital. Plant is already 80% FDA complaint & we surrendered our FDA linense in 2015. With some capex involvement, this can me FDA & GMP complaint within months and with adequate working capital one can keep ready stock & expand internationally. We will also give you buyers of each product.

- Pioneers in the pharmacy business known for world-class, quality, and efficacious medicines. - We are located on an owned property with fully functional industrial standard machinery, equipment, and all the relevant license to practice medicine manufacturing. - Business was stopped for a few years last year as we were focussing on another business. - Products are manufactured and sold under our own brand name. - Production capacity of the facility is 40,000 syrup bottles per day but we are utilizing a very small part of the capacity at the moment. - Products are sold to wholesalers, retail stores, traders, and distributors.